SANUWAVE Health to Showcase Its Shock Wave Technology at

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SANUWAVE Health to Showcase Its Shock Wave Technology at the 2016 Biofilm Science and Technology Meeting

ALPHARETTA, Ga., July 18, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), announced today that the Company will have a podium presentation at the Center for Biofilm Engineering’s 2016 Biofilm Science and Technology Meeting held at Montana State University in Bozeman, Montana on July 19-21, 2016.

SANUWAVE’s patented shock wave technology showed very promising results in removing difficult to eradicate medical biofilms created by both Gram-negative and Gram-positive species ( Pseudomonas aeruginosa and Staphylococcus aureus) in tests performed by the Center for Biofilm Engineering at Montana State University.  Other tests performed by the Center for Biofilm Engineering on marine biofilms formed from seawater organisms (provided by the Naval Research Laboratory) showed that shock wave technology is also completely removing these non-medical biofilms.  Furthermore, our shock wave technology demonstrated bacterial killing in tests performed at University of Georgia.  As a guest speaker, Dr. Iulian Cioanta, SANUWAVE’s Vice President of Research and Development, will present these results to the meeting participants in Session 2 – Industrial Biofilms, as part of the podium presentation titled “Acoustic pressure shock wave technology successfully disrupts medical and non-medical biofilms.”

“The fact that SANUWAVE was invited to present our results on biofilms removal and bacterial killing at this prestigious and exclusively focused conference on biofilms represents a great opportunity for the Company to show the extended capabilities of our technology and at the same time, emphasizes the interest of the biofilm experts in the effects of shock waves on eradication of bacteria or bacterial biofilms.  We will take this opportunity to extend the reach of our technology in new fields and to begin exploring strategic partnerships to use our shock wave technology in biofilm reduction or elimination for specific industrial or medical applications, which represents a significant market opportunity for the Company,” commented Kevin A. Richardson II, Chairman of the board of directors of SANUWAVE.

SANUWAVE Health Inc., and its wholly owned subsidiary SANUWAVE, Inc., now have 52 patents (issued or pending) in the field of shock waves used in medical and non-medical applications.

About the Center for Biofilm Engineering Montana State University's Center for Biofilm Engineering has been a world leader in biofilm research for more than 20 years.  A prestigious 11-year National Science Foundation Engineering Research Center grant awarded in 1990 paved the way for the CBE's influence in the emerging field of biofilm research.  The Center's three-fold emphasis in research, education, and industry continues to produce results and exciting opportunities for students, staff, and faculty—as well as industrial partners.

About SANUWAVE Health, Inc. SANUWAVE Health, Inc. (OTCQB:SNWV) ( www.sanuwave.com ) is a shock wave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures.  SANUWAVE’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses, producing new vascularization and microcirculatory improvement, which helps restore the body’s normal healing processes and regeneration. SANUWAVE applies its patented PACE technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Its lead product candidate for the global wound care market, dermaPACE ® , is CE Marked throughout Europe and has device license approval for the treatment of the skin and subcutaneous soft tissue in Canada, Australia and New Zealand.  In the U.S., dermaPACE is currently under the FDA’s Premarket Approval (PMA) review process for the treatment of diabetic foot ulcers.  SANUWAVE researches, designs, manufactures, markets and services its products worldwide, and believes it has demonstrated that its technology is safe and effective in stimulating healing in chronic conditions of the foot (plantar fasciitis) and the elbow (lateral epicondylitis) through its U.S. Class III PMA approved OssaTron ® device, as well as stimulating bone and chronic tendonitis regeneration in the musculoskeletal environment through the utilization of its OssaTron, Evotron ® and orthoPACE ® devices in Europe, Asia and Asia/Pacific.  In addition, there are license/partnership opportunities for SANUWAVE’s shock wave technology for non-medical uses, including energy, water, food and industrial markets.

Forward-Looking Statements This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company’s product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.

For additional information about the Company, visit www.sanuwave.com .

Contact: Millennium Park Capital LLC Christopher Wynne 312-724-7845 cwynne@mparkcm.com SANUWAVE Health, Inc. Kevin Richardson II Chairman of the Board 978-922-2447 investorrelations@sanuwave.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mace Consult Bets on Sawaya for Americas Expansion

Updated Category News Views 120

Concrete, tunnel bores, and data-center campuses rarely wait politely for a leadership transition. Mace Consult has named Mario Sawaya president of its Americas business, and the hire reads less like ceremonial executive shuffling than a deliberate move toward the thickest part of the capital-spending map. Sawaya brings more than 20 years of experience leading...

Continue Reading
Birla Carbon's Rayong Bet Tightens Asian Supply Lines

Updated Category News Views 105

Rayong just became a much louder pin on Asia's industrial map. Birla Carbon has inaugurated a 120 kMT carbon black plant in Thailand, and the significance is bigger than a ribbon-cutting photo. This is a capacity-and-location move aimed squarely at the uncomfortable part of industrial supply chains: customers need material when they need it, not after it has spent weeks...

Continue Reading
MFB Bancorp Offering Puts Chicago Bank Conversion First

Updated Category News Views 70

A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...

Continue Reading
Alphabet Lawsuit Puts Gemini Delays Under a Microscope

Updated Category News Views 173

July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 119

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading
Minno Bets on Listener Kids to Build Premium Growth

Updated Category News Views 131

Children’s media rarely gets a clean strategic move, but this one comes pretty close. Minno has signed a worldwide, multi-year agreement making it the exclusive faith-based streaming home for Listener Kids’ video library, while commissioning 66 new episodes for its own service. For a company trying to build a serious Christian family-media business, that is more than...

Continue Reading
Qiandaohu Whisky Film Puts Craft Before Market Hype

Updated Category News Views 80

Three Distillers, One Very Large Question Whisky does not become world-class because a camera crew found a pretty shoreline. That is the blunt truth sitting underneath this Nov. 19, 2026 documentary release from CCTV+. The film follows three international distillers working at three separate whisky distilleries along Qiandaohu, while also lingering on their day-to-day...

Continue Reading
EmTech AI 2027 Puts AI Ambitions Through Reality Test

Updated Category News Views 111

A three-day gathering cannot settle AI's biggest arguments, but MIT Technology Review has picked the right fight for EmTech AI 2027: make the industry face a Reality Test. The conference runs May 11–13, 2027, at MIT's campus and online, and that theme lands because the AI conversation has spent plenty of time admiring the engine while skipping the ugly maintenance bill....

Continue Reading
Titan Center Lease Gives Pocatello Retail Some Teeth

Updated Category News Views 157

A chicken sandwich lease is not usually a redevelopment thesis, yet Titan Center's new Chick-fil-A deal carries more weight than a routine restaurant announcement. Industrial Realty Group has landed a nationally recognized tenant at the entrance to a property with a long, complicated industrial past. In a smaller market, that sort of win can matter. Retail momentum is...

Continue Reading

Top 5 Most Recently Viewed Articles

Curis Advances CLL Treatment With Promising Start

Updated Category News Views 76

You know, every now and then, a glimmer of potential bites back against the usual cancer battle headlines. Today, Curis, Inc. (NASDAQ: CRIS) is that flickering hope in the often murky world of biotech, making moves to stir things up with its TakeAim CLL study. Let's do a deep dive into exactly what this could mean for the world battling chronic lymphocytic leukemia....

Continue Reading
Robust Growth Expected in Antimicrobial Coatings Market

Updated Category News Views 243

Antimicrobial Coating Market Predicted to Surge The Global antimicrobial coating market is on track for remarkable growth, projected to reach US$ 8.82 billion by 2031 from US$ 3.78 billion in 2023. This substantial growth corresponds to a compound annual growth rate (CAGR) of 11.2% throughout the forecast period. Growing Demand for Antimicrobial Coatings One of the...

Continue Reading
Royal Unibrew A/S Transactions Report by Management Personnel

Updated Category News Views 121

Recent Transactions by Management at Royal Unibrew A/S Royal Unibrew A/S, a prominent player in the beverage industry, has recently made important disclosures regarding share transactions executed by its key management personnel. This announcement is made in accordance with the regulations aimed at promoting transparency in the market. Transaction Details Overview This...

Continue Reading
Innovative Support Post Enhances Horse Racing Safety Measures

Updated Category News Views 124

Innovative Design for Racing Safety Recently, a creative inventor conceptualized an advanced support post specifically for horse racing track railings. This inventive solution was born from a desire to lessen the risk of injury to jockeys and horses. The inventor aimed to create a product that enhances safety on race tracks while providing peace of mind for everyone...

Continue Reading
Aurigo Software Partners with Philadelphia for Infrastructure Growth

Updated Category News Views 258

Aurigo Software Partners with Philadelphia for Infrastructure Growth Aurigo Software, known for its expertise in capital planning and construction management, has announced a significant partnership with the City of Philadelphia. This multiyear contract aims to leverage Aurigo's leading product suite, Masterworks, to improve infrastructure program management for the city....

Continue Reading